Welcome to DrugBase!

Posted On: 31st December 2013 5:32 pm
Over the past few days we have been working on adding a new Out of Stock section, which aims to provide a list of all drugs currently unavailable on the market or in very short supply, as well as possible alternatives for those drugs.
Posted in: New Drugs
6th November 2014 12:04 pm

The FDA has granted accelerated approval to Keytruda (pembrolizumab) for the treatment of patients with advanced or unresectable melanoma who are no longer responding to other drugs. Melanoma occurs when cancer cells form in the skin cells that make the pigment responsible for color in the skin.

Posted in: New Drugs
13th September 2014 1:25 pm

The FDA approved Sirturo (bedaquiline) as part of a combination therapy for the treatment of adults with multi-drug resistant pulmonary tuberculosis (TB) in case of absence of other alternatives.

Posted In: News
28th October 2014 2:23 am
Following a short period of shortage, the hyperthyroidism drug Eltroxin at concentrations of 50 and 100 mcg, is now again available at a price of 18 and 20 EGP, respectively; raised from its previous price of 7 and 9 EPG, respectively.

Posted In: General
27th November 2014 1:09 pm

The development of antibiotics against life-threatening infections has always been seen as the most important achievement of modern medicine. The emergence, however, of multi-drug resistant (MDR) gram negative bacteria has drastically narrowed down the therapeutic options against them; a limitation which recently has led clinicians to reevaluate the clinical application of polymyxins, an old class of antibiotics.


Share This!

Respected Sites




Need Help?

on-call support